Therefore, targeting CCHFV–LDLR interaction such as by anti-LDLR antibody, soluble LDLR or small molecules inhibiting LDLR ligand binding or its internalization may provide effective therapeutic strategies for the treatment of CCHFV infectious diseases. Here, LDLR is linked to infectious disease.